首页> 美国卫生研究院文献>ESC Heart Failure >Monitoring pulmonary pressures during long‐term continuous‐flow left ventricular assist device and fixed pulmonary hypertension: redefining alleged pathophysiological mechanisms?
【2h】

Monitoring pulmonary pressures during long‐term continuous‐flow left ventricular assist device and fixed pulmonary hypertension: redefining alleged pathophysiological mechanisms?

机译:在长期连续流动的左心室辅助装置和固定性肺动脉高压期间监测肺压:重新定义所谓的病理生理机制?

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Pulmonary hypertension (PH) type II (classified by the World Health Organization) is a common complication in chronic left‐sided heart failure. In advanced heart failure therapy, fixed PH is an absolute contraindication for heart transplantation after which a left ventricular assist device (LVAD) is the only remaining option. With remote monitoring, we can now continuously evaluate the pulmonary artery pressures during long‐term LV unloading by the LVAD. In this case, we demonstrate that fixed PH can be reversed with LVAD implantation, whereby previous thoughts of this concept should be redefined in the era of assist devices.
机译:II型肺动脉高压(PH)(由世界卫生组织分类)是慢性左心衰竭的常见并发症。在高级心力衰竭治疗中,固定的PH是心脏移植的绝对禁忌症,此后仅剩左心室辅助装置(LVAD)。通过远程监控,我们现在可以通过LVAD在长期的LV卸载过程中连续评估肺动脉压力。在这种情况下,我们证明通过LVAD植入可以逆转固定的PH,因此在辅助设备时代应重新定义该概念的先前想法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号